{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:43:59Z","timestamp":1787028239693,"version":"build-2736575974"},"reference-count":60,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Diabetes mellitus type 2 (T2DM) is a common chronic condition that presents as unsettled hyperglycemia (HG) and results from insulin resistance (IR) and \u03b2-cell dysfunction. T2DM is marked by an increased risk of microvascular and macrovascular complications, all of which can be the cause of increasing mortality. Diabetic nephropathy (DNE), neuropathy (DNU), and retinopathy (DR) are the most common complications of diabetic microangiopathy, while diabetic cardiomyopathy (DCM) and peripheral vascular diseases are the major diabetic macroangiopathy complications. Chalcones (CHs) are in the flavonoid family and are commonly found in certain plant species as intermediate metabolites in the biosynthesis of flavonoids and their derivatives. Natural CHs with different substituents exert diverse therapeutic activities, including antidiabetic ones. However, the therapeutic mechanisms of natural CHs through influencing genes and\/or signaling pathways in T2DM complications remain unknown. Therefore, this review summarizes the existing results from experimental models which highlight the mechanisms of natural CHs as therapeutic agents for T2DM complications.<\/jats:p>","DOI":"10.3390\/genes15070942","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T16:55:36Z","timestamp":1721321736000},"page":"942","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Review of Experimental Studies on Natural Chalcone-Based Therapeutic Targeting of Genes and Signaling Pathways in Type 2 Diabetes Complications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-4136","authenticated-orcid":false,"given":"Naser","family":"Alsharairi","sequence":"first","affiliation":[{"name":"Heart, Mind and Body Research Group, Griffith University, Gold Coast, QLD 4222, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes\u2014Global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Safiri, S., Karamzad, N., Kaufman, J.S., Bell, A.W., Nejadghaderi, S.A., Sullman, M.J.M., Moradi-Lakeh, M., Collins, G., and Kolahi, A.-A. (2022). Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990-2019: Results from the global burden of disease study 2019. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.838027"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Guzman-Vilca, W.C., and Carrillo-Larco, R.M. (2024). Number of people with type 2 diabetes mellitus in 2035 and 2050: A modelling study in 188 countries. Curr. Diabetes Rev.","DOI":"10.2174\/0115733998274323231230131843"},{"key":"ref_4","unstructured":"Goyal, R., Singhal, M., and Jialal, I. (2023). Type 2 Diabetes, StatPearls."},{"key":"ref_5","first-page":"45","article-title":"Type 2 diabetes mellitus, oxidative stress and inflammation: Examining the links","volume":"11","author":"Oguntibeju","year":"2019","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Burgos-Mor\u00f3n, E., Abad-Jim\u00e9nez, Z., de Mara\u00f1\u00f3n, A.M., Iannantuoni, F., Escribano-L\u00f3pez, I., L\u00f3pez-Dom\u00e8nech, S., Salom, C., Jover, A., Mora, V., and Roldan, I. (2019). Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: The battle continues. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091385"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H., and Mart\u00edn, C. (2020). Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176275"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bellou, V., Belbasis, L., Tzoulaki, I., and Evangelou, E. (2018). Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194127"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.csbj.2021.03.003","article-title":"Association of risk factors with type 2 diabetes: A systematic review","volume":"19","author":"Ismail","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Aikaeli, F., Njim, T., Gissing, S., Moyo, F., Alam, U., Mfinanga, S.G., Okebe, J., Ramaiya, K., Webb, E.L., and Jaffar, S. (2022). Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis. PLoS Glob. Public Health, 2.","DOI":"10.1371\/journal.pgph.0000599"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Huang, D., Refaat, M., Mohammedi, K., Jayyousi, A., Al Suwaidi, J., and Abi Khalil, C. (2017). Macrovascular complications in patients with diabetes and prediabetes. Biomed Res. Int., 2017.","DOI":"10.1155\/2017\/7839101"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e35285","DOI":"10.1097\/MD.0000000000035285","article-title":"Vascular complications of diabetes: A narrative review","volume":"102","author":"Lu","year":"2023","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20190120","DOI":"10.1515\/jbcpp-2019-0120","article-title":"Omics-based biomarkers in the diagnosis of diabetes","volume":"31","author":"Gan","year":"2019","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4239\/wjd.v12.i7.1070","article-title":"Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus","volume":"12","author":"Wang","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e123120189796","DOI":"10.2174\/1573399817666210101105253","article-title":"Genomics, proteomics and metabolomics approaches for predicting diabetic nephropathy in type 2 diabetes mellitus patients","volume":"17","author":"Darmayanti","year":"2021","journal-title":"Curr. Diabetes Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103331","DOI":"10.1016\/j.drudis.2022.07.016","article-title":"Current and future approaches for in vitro hit discovery in diabetes mellitus","volume":"27","author":"Zhang","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Rudrapal, M., Khan, J., Bin Dukhyil, A.Z., Alarousy, R.M.I.I., Attah, E.I., Sharma, T., Khairnar, S.J., and Bendale, A.R. (2021). Chalcone scaffolds, bioprecursors of flavonoids: Chemistry, bioactivities, and pharmacokinetics. Molecules, 26.","DOI":"10.3390\/molecules26237177"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Rajendran, G., Bhanu, D., Aruchamy, B., Ramani, P., Pandurangan, N., Bobba, K.N., Oh, E.J., Chung, H.Y., Gangadaran, P., and Ahn, B.-C. (2022). Chalcone: A promising bioactive scaffold in medicinal chemistry. Pharmaceuticals, 15.","DOI":"10.3390\/ph15101250"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Constantinescu, T., and Lungu, C.N. (2021). Anticancer activity of natural and synthetic chalcones. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111306"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Maisto, M., Marzocchi, A., Keivani, N., Piccolo, V., Summa, V., and Tenore, G.C. (2023). Natural chalcones for the management of obesity disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115929"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/j.bmcl.2012.04.108","article-title":"Synthesis of chalcone derivatives as potential anti-diabetic agents","volume":"22","author":"Hsieh","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.2147\/DDDT.S316185","article-title":"Design, synthesis, characterization and in vivo antidiabetic activity evaluation of some chalcone derivatives","volume":"15","author":"Kahssay","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e22546","DOI":"10.1016\/j.heliyon.2023.e22546","article-title":"Chalcones: The flavonoid derivatives synthesis, characterization, their antioxidant and in vitro\/in vivo antidiabetic potentials","volume":"9","author":"Uddin","year":"2023","journal-title":"Heliyon"},{"key":"ref_25","first-page":"e37267","article-title":"A Review of the in vitro inhibition of \u03b1-amylase and \u03b1-glucosidase by chalcone derivatives","volume":"15","author":"Tran","year":"2023","journal-title":"Cureus"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejmech.2015.01.051","article-title":"Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives","volume":"92","author":"Mahapatra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2174\/0929867325666181001112226","article-title":"A systematic review on anti-diabetic properties of chalcones","volume":"27","author":"Rocha","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4560012","DOI":"10.1155\/2021\/4560012","article-title":"Pharmacological actions, molecular mechanisms, pharmacokinetic progressions, and clinical applications of hydroxysafflor yellow A in antidiabetic research","volume":"2021","author":"Zhang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/jf9040723","article-title":"Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation","volume":"58","author":"Li","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/tox.23553","article-title":"Isoliquiritigenin ameliorates advanced glycation end-products toxicity on renal proximal tubular epithelial cells","volume":"37","author":"Lin","year":"2022","journal-title":"Environ. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106813","DOI":"10.1016\/j.intimp.2020.106813","article-title":"Protective effect of isoliquiritigenin on experimental diabetic nephropathy in rats: Impact on Sirt-1\/NF\u03baB balance and NLRP3 expression","volume":"87","author":"Alzahrani","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00210-023-02598-z","article-title":"Isoliquiritigenin attenuates high glucose-induced proliferation, inflammation, and extracellular matrix deposition in glomerular mesangial cells by suppressing JAK2\/STAT3 pathway","volume":"397","author":"Zhang","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1080\/21655979.2021.2006978","article-title":"Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2\/STAT3 pathway in streptozotocin-induced diabetic rats","volume":"12","author":"Sun","year":"2021","journal-title":"Bioengineered"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1600488","DOI":"10.1002\/mnfr.201600488","article-title":"Modulation of VEGF signaling in a mouse model of diabetes by xanthohumol and 8-prenylnaringenin: Unveiling the angiogenic paradox and metabolism interplay","volume":"61","author":"Costa","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lu\u00eds, C., Costa, R., Rodrigues, I., Castela, A., Coelho, P., Guerreiro, S., Gomes, J., Reis, C., and Soares, R. (2018). Xanthohumol and 8-prenylnaringenin reduce type 2 diabetes-associated oxidative stress by downregulating galectin-3. Porto Biomed. J., 4.","DOI":"10.1016\/j.pbj.0000000000000023"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000528650","article-title":"Protective Effects of xanthohumol against diabetic nephropathy in a mouse model","volume":"48","author":"Li","year":"2023","journal-title":"Kidney Blood Press. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1039\/D1FO01630J","article-title":"Impact of licochalcone A on the progression of diabetic nephropathy in type 2 diabetes mellitus of C57BL\/6 mice","volume":"12","author":"Luo","year":"2021","journal-title":"Food Funct."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1039\/D2FO00570K","article-title":"Phloretin ameliorates diabetic nephropathy by inhibiting nephrin and podocin reduction through a non-hypoglycemic effect","volume":"13","author":"Liu","year":"2022","journal-title":"Food Funct."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7805393","DOI":"10.1155\/2020\/7805393","article-title":"Protective effect of hydroxysafflor yellow A on nephropathy by attenuating oxidative stress and inhibiting apoptosis in induced type 2 diabetes in rat","volume":"2020","author":"Lee","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2462039","DOI":"10.1155\/2020\/2462039","article-title":"Protective effects of two safflower derived compounds, kaempferol and hydroxysafflor yellow A, on hyperglycaemic stress-induced podocyte apoptosis via modulating of macrophage M1\/M2 polarization","volume":"2020","author":"Li","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Li, Q., Li, F., Chen, Z., Deng, S., Cao, X., and Tang, N. (2020). Hydroxysafflor yellow A improves diabetes-induced renal fibrosis. Arch. Med. Sci.","DOI":"10.5114\/aoms.2020.97813"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Dong, W.-H., Chu, Q.-Q., Liu, S.-Q., Deng, D.-T., and Xu, Q. (2020). Isobavachalcone ameliorates diabetic nephropathy in rats by inhibiting the NF-\u03baB pathway. J. Food Biochem., 44.","DOI":"10.1111\/jfbc.13405"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"108610","DOI":"10.1016\/j.intimp.2022.108610","article-title":"Cardamomin protects from diabetes-induced kidney damage through modulating PI3K\/AKT and JAK\/STAT signaling pathways in rats","volume":"107","author":"Gao","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s11033-020-05605-1","article-title":"PPAR-Gamma as putative gene target involved in butein mediated anti-diabetic effect","volume":"47","author":"Prabhu","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jnutbio.2017.05.001","article-title":"Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy","volume":"47","author":"Yerra","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.biopha.2018.02.135","article-title":"Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats","volume":"101","author":"Balaha","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2022.09.095","article-title":"Norkurarinone and isoxanthohumol inhibit high glucose and hypoxia-induced angiogenesis via improving oxidative stress and regulating autophagy in human retinal microvascular endothelial cells","volume":"634","author":"Zhao","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1515\/biol-2022-0030","article-title":"Hydroxysafflor yellow A improved retinopathy via Nrf2\/HO-1 pathway in rats","volume":"17","author":"Sun","year":"2022","journal-title":"Open Life Sci."},{"key":"ref_49","first-page":"812","article-title":"Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db\/db mice","volume":"19","author":"Zhang","year":"2013","journal-title":"Mol. Vis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-022-04504-2","article-title":"Phloretin inhibits glucose transport and reduces inflammation in human retinal pigment epithelial cells","volume":"478","author":"Hytti","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10895-023-03147-w","article-title":"Butein inhibits the glycation of \u03b1-crystallin: An approach in prevention of retinopathy","volume":"33","author":"Liu","year":"2023","journal-title":"J. Fluoresc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153319","DOI":"10.1016\/j.phymed.2020.153319","article-title":"Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress","volume":"78","author":"Gu","year":"2020","journal-title":"Phytomedicine"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Yao, R., Cao, Y., Jiang, R., Zhang, X., Li, F., and Wang, S. (2021). Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice. Biomed. Chromatogr., 35.","DOI":"10.1002\/bmc.5173"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"263845","DOI":"10.1155\/2013\/263845","article-title":"Investigation of the protective effects of phlorizin on diabetic cardiomyopathy in db\/db mice by quantitative proteomics","volume":"2013","author":"Cai","year":"2013","journal-title":"J. Diabetes Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ying, Y., Jin, J., Ye, L., Sun, P., Wang, H., and Wang, X. (2018). Phloretin prevents diabetic cardiomyopathy by dissociating Keap1\/Nrf2 complex and inhibiting oxidative stress. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00774"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.18632\/aging.101954","article-title":"Phloretin protects against cardiac damage and remodeling via restoring SIRT1 and anti-inflammatory effects in the streptozotocin-induced diabetic mouse model","volume":"11","author":"Ying","year":"2019","journal-title":"Aging"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/13880209.2023.2225543","article-title":"Hydroxysafflor yellow A inhibits endothelial cell ferroptosis in diabetic atherosclerosis mice by regulating miR-429\/SLC7A11","volume":"61","author":"Rong","year":"2023","journal-title":"Pharm. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/09168451.2019.1699396","article-title":"Low-dose phloretin alleviates diabetic atherosclerosis through endothelial KLF2 restoration","volume":"84","author":"Xia","year":"2020","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0960327119831065","article-title":"Hydroxysafflor yellow A attenuates high glucose-induced human umbilical vein endothelial cell dysfunction","volume":"38","author":"Chen","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"106205","DOI":"10.1016\/j.phrs.2022.106205","article-title":"Phloretin ameliorates diabetes-induced endothelial injury through AMPK-dependent anti-EndMT pathway","volume":"179","author":"Mao","year":"2022","journal-title":"Pharmacol. Res."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/7\/942\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:19:22Z","timestamp":1760109562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/7\/942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["genes15070942"],"URL":"https:\/\/doi.org\/10.3390\/genes15070942","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}